Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
The companies also have an expanded three-year software agreement that will increase access for Novartis to Schrödinger’s ...
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Schrodinger, Inc. (NASDAQ:SDGR) shares are trading higher on Tuesday. The company disclosed a research collaboration and ...
Schrödinger gains on Novartis deal despite Q3 miss
Schrödinger (NASDAQ:SDGR) shares traded higher on Tuesday despite reporting lower-than-expected Q3 2024 financials after the ...
The Pharma Letter1d
Schrödinger announces collaboration with Novartis
Physics-based US software specialist Schrödinger’s shares leapt nearly 14% to $22.25 on the back of news that it has entered ...
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
Schrödinger today announced a multi-target collaboration and expanded software licensing agreement with Novartis.
FierceBiotech2d
Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact
Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...
Business Insider1d
Schrödinger Reports Q3 2024 Earnings and New Novartis Collaboration
In its recent earnings release for the third quarter of 2024, Schrödinger reported significant developments, including a new collaboration with Novartis, which will see an upfront payment of $150 ...
Schrodinger’s Promising Growth Potential Highlighted by Novartis Partnership and Strong Fundamentals
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...
ENDPOINTS NEWS2d
No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use
Novartis will pay $150 million upfront to Schrödinger, in a pact announced Tuesday to work together on several preclinical ...
Bill Gates & Blackrock schwören auf diese Aktie – dieser Mega-Deal könnte die Aktie befeuern
Die Nachrichten kamen an der Börse gut an; die Aktie beendete den US-Handel mit einem satten Kursplus von 13 Prozent. Laut ...
Cash2d
Novartis und Schrödinger schliessen Forschungskooperation und Lizenzvereinbarung
Die US-Biotechfirma Schrödinger hat eine Forschungskooperation und Lizenzvereinbarung zur Entdeckung neuer Zielmoleküle mit ...
Investing2d
Schrödinger sichert sich Novartis-Deal mit potenziellem Wert von 2,3 Milliarden US-Dollar
NEW YORK - Schrödinger, Inc. (NASDAQ: SDGR), ein Unternehmen, das sich auf computergestützte molekulare Entdeckungen spezialisiert hat, gab eine bedeutende Kooperations- und Lizenzvereinbarung mit dem ...